Repeated injury to airways from exposure to irritants (e.g., cigarette smoke) initiates the process of airway remodeling which in some patients, can result in permanent abnormalities in lung function. Chronic airway inflammation and regulation of genes that act down stream of inflammatory mediators play a major role in the pathogenesis of airway remodeling in smokers with chronic obstructive pulmonary disease (COPD). By far the most important risk factor for development of COPD is smoking but a subset of heavy smokers will have a greater decline in lung function than expected and develop severe or end- stage COPD. While inflammatory cells have been found in the lung of smokers with COPD, the nature of """"""""the inflammatory process"""""""" that may be key to understanding the pathogenesis of this disease remains obscure. We have found that activated T lymphocytes persist in the lungs of ex-smokers with end-stage COPD despite years of smoking cessation. Based on the literature and our own data we propose to test the hypothesis that loss of lung function in ex-smokers with end-stage COPD, is mediated through cognate immune mechanisms driven by the T helper 1 (Th1) subset of T lymphocytes. Specifically, a subset of smokers develops an aberrant lung Th1 immune response that orchestrates progressive lung destruction. Furthermore we hypothesize that ex-smokers who develop end-stage COPD can be distinguished from smokers with no or mild COPD by different patters of lung gene activation. To explore these hypotheses, in collaboration with the Houston Veterans Affairs Medical Center (VAMC) lung volume reduction surgery (LVRS) clinical trial, we plan to characterize immunological and genetic phenotypes of 12 non-atopic end-stage COPD, 24 mild COPD with emphysema, and 24 mild or no COPD human ex-smokers. We will determine the immune characteristics of patients with end-stage COPD by addressing the following specific aims:
Aim 1) To determine the dominant immune phenotype of ex- smokers with end-stage COPD.
Aim 2) To determine the mechanism of T cell activation in ex-smokers with end-stage COPD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL072419-04
Application #
6906518
Study Section
Special Emphasis Panel (ZHL1-CSR-A (S1))
Program Officer
Croxton, Thomas
Project Start
2002-07-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2007-06-30
Support Year
4
Fiscal Year
2005
Total Cost
$263,375
Indirect Cost
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Hong, M J; Gu, B H; Madison, M C et al. (2018) Protective role of ?? T cells in cigarette smoke and influenza infection. Mucosal Immunol 11:894-908
Liu, Jian; Cho, Sung-Nam; Akkanti, Bindu et al. (2015) ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis. Cell Rep :
Xu, Chuang; Hesselbacher, Sean; Tsai, Chu-Lin et al. (2012) Autoreactive T Cells in Human Smokers is Predictive of Clinical Outcome. Front Immunol 3:267
Kheradmand, Farrah; Shan, Ming; Xu, Chuang et al. (2012) Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence. Expert Rev Clin Immunol 8:285-92
Shan, Ming; Yuan, Xiaoyi; Song, Li-Zhen et al. (2012) Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med 4:117ra9
Hesselbacher, Sean E; Ross, Robert; Schabath, Matthew B et al. (2011) Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers. Int J Environ Res Public Health 8:1324-40
Hong, Jeong-Soo; Greenlee, Kendra J; Pitchumani, Ramanan et al. (2011) Dual protective mechanisms of matrix metalloproteinases 2 and 9 in immune defense against Streptococcus pneumoniae. J Immunol 186:6427-36
Singh, Manisha; Lee, Seung-Hyo; Porter, Paul et al. (2010) Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 125:1369-1378.e2
Shan, Ming; Cheng, Han-Fang; Song, Li-Zhen et al. (2009) Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci Transl Med 1:4ra10
Greenlee, Kendra J; Werb, Zena; Kheradmand, Farrah (2007) Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 87:69-98

Showing the most recent 10 out of 12 publications